Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model

Cancer Causes and Control

Volumn 23, Issue 1, 2012, Pages 175-185

  Lin, Ray S ^a   Plevritis, Sylvia K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast neoplasms; Cancer screening (early detection of cancer); Computer simulation; Lung neoplasms; Mathematical model (models, theoretical)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; METASTASIS POTENTIAL; MODEL; NATURAL HISTORY MODEL; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; TUMOR GROWTH; TUMOR VOLUME;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; SEER PROGRAM; UNITED STATES;

EID: 82955163265     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9866-9     Document Type: Article

References (40)

1. SEERStat*Surveillance, Epidemiology, and End Results (SEER) Program ( www.seer.cancer.gov ) SEER*Stat Database: Incidence-SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2007 Sub (1973-2005 varying)-Linked To County Attributes-Total U.S., 1969-2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission
2. RA Smith V Cokkinides OW Brawley 2008 Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues CA Cancer J Clin 58 161 179 18443206 10.3322/CA.2007.0017 (Pubitemid 351830300)
3. Brown PO, Palmer C (2009) The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Med 6: e1000114-e
4. YL Chia P Salzman SK Plevritis PW Glynn 2004 Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration Stat Methods Med Res 13 507 524 15587436 10.1191/0962280204sm380ra (Pubitemid 39562705)
5. JA Nelder R Mead 1965 A simplex method for function minimization Comput J 7 308 313
6. Alberg AJ, Ford JG, Samet JM (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines, 2nd edn. Chest 132: 29S-55S-29S-55S
7. PM Marcus EJ Bergstralh RM Fagerstrom, et al. 2000 Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up J Natl Cancer Inst 92 1308 1316 10944552 10.1093/jnci/92.16.1308 1:STN:280:DC%2BD3cvjvVCluw%3D%3D (Pubitemid 30660590)
8. PM Marcus EJ Bergstralh MH Zweig A Harris KP Offord RS Fontana 2006 Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis J Natl Cancer Inst 98 748 756 16757699 10.1093/jnci/djj207 (Pubitemid 43983298)
9. MA Pashkevich BM Sigal SK Plevritis 2009 Modeling the transition of lung cancer from early to advanced stage Cancer Causes Control 20 1559 1569 19629730 10.1007/s10552-009-9401-4
10. KA Cronin B Yu M Krapcho, et al. 2005 Modeling the dissemination of mammography in the United States Cancer Causes Control 16 701 712 16049809 10.1007/s10552-005-0693-8 (Pubitemid 41110961)
11. A Mariotto EJ Feuer LC Harlan LM Wun KA Johnson J Abrams 2002 Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999 J Natl Cancer Inst 94 1626 1634 12419789 1:CAS:528:DC%2BD38XosFOgsb8%3D (Pubitemid 35378728)
12. KC Chu CR Smart RE Tarone 1988 Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial J Natl Cancer Inst 80 1125 1132 3411625 10.1093/jnci/80.14.1125 1:STN:280: DyaL1czhslSjtA%3D%3D
13. M Tubiana MH Pejovic S Koscielny N Chavaudra E Malaise 1989 Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer Int J Cancer 44 17 22 2744888 10.1002/ijc.2910440104 1:STN:280: DyaL1MzgslKhtg%3D%3D (Pubitemid 19184670)
14. Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S (2008) Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Research: BCR 10: R41-R
15. T Arai T Kuroishi Y Saito Y Kurita T Naruke M Kaneko 1994 Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group Jap J Clin Oncol 24 199 204 1:STN:280:DyaK2czltF2gtA%3D%3D
16. DM Geddes 1979 The natural history of lung cancer: a review based on rates of tumour growth Br J Dis Chest 73 1 17 435370 10.1016/0007-0971(79)90002- 0 1:STN:280:DyaE1M7ms1Wmsw%3D%3D (Pubitemid 9097173)
17. National Cancer Institute. The National Lung Screening Trial. [cited Nov 2010] Available from: http://www.cancer.gov/clinicaltrials/noteworthy-trials/ nlst
18. National Lung Screening Trial Research Team DR Aberle CD Berg, et al. 2011 The national lung screening trial: overview and study design Radiology 258 243 253 21045183 10.1148/radiol.10091808
19. SJ Swensen JR Jett TE Hartman, et al. 2005 CT screening for lung cancer: five-year prospective experience Radiology 235 259 265 15695622 10.1148/radiol.2351041662 (Pubitemid 40432263)
20. SJ Swensen JR Jett JA Sloan, et al. 2002 Screening for lung cancer with low-dose spiral computed tomography Am J Respir Crit Care Med 165 508 513 11850344 (Pubitemid 34165474)
21. JS Michaelson M Silverstein J Wyatt, et al. 2002 Predicting the survival of patients with breast carcinoma using tumor size Cancer 95 713 723 12209713 10.1002/cncr.10742 (Pubitemid 34839661)
22. BJ Flehinger M Kimmel MR Melamed 1988 Natural history of adenocarcinoma-large cell carcinoma of the lung: conclusions from screening programs in New York and Baltimore J Natl Cancer Inst 80 337 344 2833601 10.1093/jnci/80.5.337 1:STN:280:DyaL1c7ovVaisA%3D%3D
23. M Kimmel BJ Flehinger 1991 Nonparametric estimation of the size-metastasis relationship in solid cancers Biometrics 47 987 1004 1742451 10.2307/2532654 1:STN:280:DyaK38%2FnsFyktw%3D%3D
24. SYGL Tan GJ van Oortmarssen HJ de Koning R Boer JDF Habbema 2006 The MISCAN-Fadia continuous tumor growth model for breast cancer J Natl Cancer Inst Monogr 36 56 65 17032895 10.1093/jncimonographs/lgj009
25. FC Detterbeck CJ Gibson 2008 Turning gray: the natural history of lung cancer over time J Thorac Oncol 3 781 792 18594326 10.1097/JTO.0b013e31817c9230
26. EM Schultz GA Silvestri MK Gould 2008 Variation in experts' beliefs about lung cancer growth, progression, and prognosis J Thorac Oncol 3 422 426 18379363 10.1097/JTO.0b013e318167146b (Pubitemid 351489485)
27. AK Laird 1964 Dynamics of tumor growth Br J Cancer 13 490 502 14219541 10.1038/bjc.1964.55 1:STN:280:DyaF2M%2Fitl2nsg%3D%3D
28. CI Henschke DI McCauley DF Yankelevitz, et al. 1999 Early Lung Cancer Action Project: overall design and findings from baseline screening Lancet 354 99 105 10408484 10.1016/S0140-6736(99)06093-6 1:STN:280:DyaK1MzjsV2luw%3D%3D (Pubitemid 29313143)
29. CI Henschke DF Yankelevitz DM Libby MW Pasmantier JP Smith OS Miettinen 2006 Survival of patients with stage I lung cancer detected on CT screening N Engl J Med 355 1763 1771 17065637 10.1056/NEJMoa060476 (Pubitemid 44631359)
30. PB Bach JR Jett U Pastorino MS Tockman SJ Swensen CB Begg 2007 Computed tomography screening and lung cancer outcomes JAMA 297 953 961 17341709 10.1001/jama.297.9.953 1:CAS:528:DC%2BD2sXisFKns7k%3D (Pubitemid 46376749)
31. EF Patz PC Goodman G Bepler 2000 Screening for lung cancer N Engl J Med 343 1627 1633 11096172 10.1056/NEJM200011303432208 (Pubitemid 32162988)
32. PB Bach 2008 Lung cancer screening J Natl Compr Canc Netw 6 271 275 18377845 (Pubitemid 351488821)
33. PB Bach 2008 Is our natural-history model of lung cancer wrong? Lancet Oncol 9 693 697 18598934 10.1016/S1470-2045(08)70176-1 (Pubitemid 351878055)
34. DV Gold M Goggins DE Modrak, et al. 2010 Detection of early-stage pancreatic adenocarcinoma Cancer Epidemiol Biomarkers Prev 19 2786 2794 20810605 10.1158/1055-9965.EPI-10-0667 1:CAS:528:DC%2BC3cXhtl2rsLfM
35. D Kanojia M Garg S Gupta A Gupta A Suri 2009 Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer Cancer Epidemiol Biomarkers Prev 18 630 639 19190149 10.1158/1055-9965.EPI-08-0629 1:CAS:528:DC%2BD1MXhslSgsr4%3D
36. E Gordian K Ramachandran IM Reis M Manoharan MS Soloway R Singal 2010 Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease Cancer Epidemiol Biomarkers Prev 19 1984 1991 20647404 10.1158/1055-9965.EPI-10-0287 1:CAS:528:DC%2BC3cXpvVejsb8%3D
37. DH Conrad J Goyette PS Thomas 2008 Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening J Gen Intern Med 23 Suppl 1 78 84 18095050 10.1007/s11606-007-0411-1 (Pubitemid 350295398)
38. Lutz AM, Willmann JK, Cochran FV, Ray P, Gambhir SS (2008) Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes. PLoS Medicine. 5: e170-e
39. M Cristofanilli GT Budd MJ Ellis, et al. 2004 Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 781 791 15317891 10.1056/NEJMoa040766 1:CAS:528:DC%2BD2cXntVeitb4%3D (Pubitemid 39095313)
40. M Cristofanilli DF Hayes GT Budd, et al. 2005 Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer J Clin Oncol 23 1420 1430 15735118 10.1200/JCO.2005.08.140